Loading today’s stories
Invest1 distinct publisher3 min readPublished
A Seeking Alpha contributor cut Edenred to hold after regulatory margin pressure in Italy and Brazil reset the earnings base, yet the 30 euro target values normalised EPS at 12.5 times, not the 15 the same note calls justified.
The Investor · Invest desk
Compiled by The InvestorSomething wrong?How this is made
Follow any of these and your For You feed starts watching them — no settings page required.
invest
BAE's H1-26 beat is a capex story wearing a growth multiple1 distinct publisher
invest
IHI prices a three-stock bet at 34 times earnings1 distinct publisher
invest
Nvidia into August 26: the beat is priced, the $210 line is not1 distinct publisher
invest
Teekay Tankers' record half rests on a $9,700 breakeven, not on the rate print1 distinct publisher
The note asks you to hold two numbers at once, a normalised 2.4 euros of earnings per share and a justified multiple of 15 [4][5], and multiplied together they give 36 euros rather than the 30 the target names [1][2], which means the figure actually doing the work is 12.5 times [2], a discount of roughly 17 per cent to the author's own fair multiple [5]. That gap looks like ordinary prudence, but it also reads as a quiet admission that the author does not yet trust the earnings base he has just reset [3].
Work the other end and the run reads differently. If the shares are approaching the 30 euro target [8] after gaining more than 90 per cent since March [1], March was somewhere near 16 [4], which is the price of a stock where the regulatory news had already arrived and the model had not.
What the summary does not do is describe what Italy and Brazil actually changed; it says regulatory headwinds pressured margins and forced a reset of growth and earnings expectations while revenue stayed resilient and market positions solid [3][6]. The inference is mine, not the note's, but a top line that holds while margins compress is what a squeeze on merchant economics looks like from outside the building: the number of meals bought does not move, the spread the issuer keeps on each one does. That is the whole exposure of the voucher model, and it sits with rule-writers rather than with employers.
The note sets up two branches and picks neither. If the margin hit is one-off and repairs itself, 15 times a base above 2.4 euros carries fair value past 36 [1] and today's price is a floor rather than a ceiling. If regulated merchant economics are permanent, 12.5 times [2] is not caution but the new multiple, and yield plus quality is the entire remaining case [7]. This is probably wrong, but the honest reading of the arithmetic is that the 12.5 is the author's live estimate and the 15 is inherited from the pre-regulation Edenred. The thesis fails the moment the company reports margin recovery in Italy and Brazil with earnings above the 2.4 euro base [4], because then the multiple was right, the target was merely a queue ticket, and the de-rating was a trading window rather than a repricing of the franchise.
One caveat that is not small: this is a single contributor's model, published with a disclosed long position in Edenred and a statement that the author is not licensed to give financial advice [9], and the disclosure names the ADR line even as the same piece says the author owns European local tickers rather than ADRs [10]. No company guidance appears in the material at all. Price target and value are two different numbers, and in this note they sit 6 euros apart inside the same argument [1].
Ranked by verification strength, evidence, and original report placement.
A Seeking Alpha contributor downgraded Edenred to a 'HOLD' rating after a run-up of more than 90 per cent since March.
The note sets a new price target of 30 euros a share on Edenred.
Normalised earnings per share for Edenred are now set at 2.4 euros a share.
The note applies a justified price/earnings multiple of 15 times.
The note says yield and quality remain strengths but upside is limited, and that Edenred is no longer considered cheap at current levels.
The note's headline describes the shares as 'Approaching PT' after being 'Close To 90% Since March'.
Distinct publishers with included, body-backed reporting in this cluster.
seekingalpha.com
1 article · August 30, 2026
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
One contributor's page, start to finish
Every figure in this story — the 30 euro target, the 2.4 euro normalised earnings base, the 15 times multiple, the regulatory squeeze in Italy and Brazil — comes from the summary bullets of a single Seeking Alpha contributor who states in the same piece that he is not licensed to give advice. No filing, no company release, no second analyst. What is verifiable is that the note says these things; nothing here tests whether they hold.
Nothing here to adopt
A rating change is not something that ships. Seeking Alpha gives no fund positioning, no flows, no market reaction — nothing that would show whether anyone acted on the call. We leave this unscored rather than dress up the silence.
The arithmetic undercuts the headline
The note names 15 times earnings as justified, then sets a target that pays 12.5 — about 17 per cent under its own yardstick and 6 euros short of where that yardstick points. Meanwhile 'Approaching PT' promises a tidy round trip without printing a price to measure it against. The confidence of the framing runs ahead of the numbers holding it up, even though the underlying call is a cautious one.
Disclosed long, subscription attached
The author is long Edenred — the European line, not the ADR — and says so plainly, which is the honest version of a conflict rather than a buried one. The same summary routes readers to his paid Wolf of Value service, and Seeking Alpha compensates him for the piece. Calling a stock you own no longer cheap cuts against your own book and deserves credit; the subscription funnel still explains why the note exists at all.
Certain of the text, not of the case
We can quote the note exactly, so what it argues is not in question. Whether Italian and Brazilian regulation truly reset Edenred's earnings power is one sentence with no numbers, and the unexplained multiple leaves the central valuation judgement wobbling. One author, one page, no outside check.